AON vs NU

AON's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive assessment of bankruptcy risk. The company trades at a premium valuation with a P/E of 26.88 versus sector average of 21.49, yet demonstrates robust profitability (ROE: 37.69%, Operating Margin: 20.36%) and strong earnings growth (YoY: +34.4%). However, weak technical trend (0/100), bearish insider activity, and declining short-term EPS momentum (-20.7% Q/Q) offset these strengths. The stock is trading well above the conservative Graham Number of $102.27 but below the growth-based intrinsic value of $371.7, suggesting the market prices in continued growth.

NU presents a stark contrast between traditional accounting health and explosive growth metrics, highlighted by a weak Piotroski F-Score of 2/9. While the deterministic health score is poor, the company's operational performance is exceptional, featuring 60.9% YoY earnings growth and a highly attractive PEG ratio of 0.85. The current price of $14.48 trades at a significant premium to the Graham Number ($5.51) but remains below the growth-based intrinsic value of $17.11. Ultimately, the strong ROE of 30.28% and aggressive scaling suggest a high-growth fintech trajectory that outweighs short-term deterministic health warnings.